BF Biosciences Limited (PSX:BFBIO)

Pakistan flag Pakistan · Delayed Price · Currency is PKR
161.14
-0.75 (-0.46%)
At close: Aug 1, 2025
-0.46%
Market Cap14.23B
Revenue (ttm)4.96B
Net Income (ttm)391.70M
Shares Out88.33M
EPS (ttm)5.24
PE Ratio30.73
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume226,202
Average Volume426,602
Open163.00
Previous Close161.89
Day's Range158.00 - 163.00
52-Week Range76.06 - 253.97
Betan/a
RSI41.09
Earnings DateOct 24, 2025

About BF Biosciences

BF Biosciences Limited, a diversified biotech pharmaceutical company, manufactures, imports, and sells pharmaceutical products. It offers a range of products in the areas of nephrology, cardiology, gastroenterology, diabetes, oncology, anti-viral, and hepatology. The company was incorporated in 2006 and is headquartered in Raiwind, Pakistan. BF Biosciences Limited is a subsidiary of Ferozsons Laboratories Limited. [Read more]

Industry Pharmaceutical Preparations
Founded 2006
Country Pakistan
Stock Exchange Pakistan Stock Exchange
Ticker Symbol BFBIO
Full Company Profile

Financial Performance

In 2024, BF Biosciences's revenue was 3.66 billion, an increase of 102.19% compared to the previous year's 1.81 billion. Earnings were 385.41 million, an increase of 158.57%.

Financial Statements

News

There is no news available yet.